Published in Lancet on December 01, 1990
Asthma: a follow up statement from an international paediatric asthma consensus group. Arch Dis Child (1992) 3.75
Beta 2-agonists in asthma. Lancet (1991) 1.99
Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Thorax (1999) 1.45
Beta 2-agonists in asthma. Lancet (1991) 1.34
Pharmacotherapy and airway remodelling in asthma? Thorax (2003) 1.11
The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists. Br J Clin Pharmacol (1991) 1.05
Allergen-induced airway inflammation and its therapeutic intervention. Allergy Asthma Immunol Res (2009) 1.02
Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol (1991) 0.96
The current debate concerning beta-agonists in asthma: a review. J R Soc Med (1993) 0.92
Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance? Br J Clin Pharmacol (1992) 0.92
Recent advances in asthma. Postgrad Med J (1992) 0.92
Measurement of airway hyperresponsiveness: new considerations. Thorax (1998) 0.91
Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol (1992) 0.90
Beta 2 agonists and asthma. BMJ (1991) 0.89
Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br J Pharmacol (1993) 0.86
Effect of BW B70C, a novel inhibitor of arachidonic acid 5-lipoxygenase, on allergen-induced bronchoconstriction and late-phase lung eosinophil accumulation in sensitised guinea-pigs. Agents Actions (1993) 0.83
Changes in psychosocial adjustment after renal transplantation. Arch Dis Child (1991) 0.83
Effects of BRL 38227 on neurally-mediated responses in the guinea-pig isolated bronchus. Br J Pharmacol (1992) 0.83
Do bronchodilators adversely affect the prognosis of bronchial hyperresponsiveness? Thorax (1993) 0.82
Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro. Br J Pharmacol (1996) 0.78
Tolerance with beta 2-adrenoceptor agonists: time for reappraisal. Br J Clin Pharmacol (1995) 0.78
Effects of beta 2-adrenoceptor agonists on anti-IgE-induced contraction and smooth muscle reactivity in human airways. Br J Pharmacol (1995) 0.77
Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child (1992) 0.77
The pharmacological modulation of allergen-induced asthma. Inflammopharmacology (2012) 0.76
Asthma care in general practice. Br J Gen Pract (1991) 0.75
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor. Thorax (1992) 0.75
[Long-acting beta(2)-adrenoceptor agonists for asthma and COPD]. Med Klin (Munich) (1997) 0.75
Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet (2001) 11.06
Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med (1990) 7.46
A self management plan in the treatment of adult asthma. Thorax (1989) 5.85
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med (1999) 4.72
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J Clin Oncol (2002) 4.25
Characterization of the imitation switch subfamily of ATP-dependent chromatin-remodeling factors in Saccharomyces cerevisiae. Genes Dev (1999) 4.25
Mucosal inflammation in asthma. Am Rev Respir Dis (1990) 4.11
bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med (1993) 4.05
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis (1989) 3.86
Penicillin Treatment of Early Syphilis-A Preliminary Report. Am J Public Health Nations Health (1943) 3.86
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
The parahippocampal place area: recognition, navigation, or encoding? Neuron (1999) 3.56
Occupational therapy for independent-living older adults. A randomized controlled trial. JAMA (1997) 3.47
Development of the nursing section of the community health team. Br Med J (1968) 3.40
Prevalence of respiratory symptoms among 7 and 11 year old schoolchildren and association with asthma. Arch Dis Child (1989) 3.25
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996). Pharmacoeconomics (2001) 3.03
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol (1996) 2.92
Behavior of cultured cells on substrata of variable adhesiveness. Exp Cell Res (1973) 2.87
Rhinoviruses infect the lower airways. J Infect Dis (2000) 2.83
Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci U S A (1991) 2.82
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial. Neurology (2012) 2.54
Dog bites of the face: a 15 year review. Br J Plast Surg (1983) 2.51
Diagnosis of equine monocytic ehrlichiosis (Potomac horse fever) by indirect immunofluorescence. J Am Vet Med Assoc (1986) 2.49
Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med (1995) 2.48
Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation (2001) 2.46
Health checks for people over 75. BMJ (1992) 2.46
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis (1990) 2.45
Intra-abdominal hypertension and abdominal compartment syndrome in burn patients. J Trauma (2000) 2.42
Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J (2000) 2.42
Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study. BMJ (1997) 2.40
Centripetal transport of attached particles on both surfaces of moving fibroblasts. Exp Cell Res (1972) 2.35
Aetiology of chronic heart block. A clinico-pathological correlation in 65 cases. Br Heart J (1969) 2.31
Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1. Am J Respir Cell Mol Biol (1995) 2.30
Personal exposures of children to nitrogen dioxide relative to concentrations in outdoor air. Occup Environ Med (2000) 2.29
Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ (1992) 2.25
The requirement for macrophages in the in vitro immune response. Cell Immunol (1971) 2.24
Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax (1984) 2.20
Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 2.19
Research ethics committee audit: differences between committees. J Med Ethics (1996) 2.16
Specialist outreach clinics. BMJ (1994) 2.14
Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest (1998) 2.13
Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther (2014) 2.11
Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science (1974) 2.11
Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol (1999) 2.10
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol (1983) 2.10
Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis (1984) 2.08
Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn Mem (1999) 2.06
Longitudinal changes in skin-prick test reactivity over 2 years in a population of schoolchildren with respiratory symptoms. Clin Exp Allergy (1992) 2.06
Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J Infect Dis (1991) 2.06
Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. Br Med J (Clin Res Ed) (1987) 2.05
The natural history of respiratory symptoms in a cohort of adolescents. Am J Respir Crit Care Med (1998) 2.05
Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol (2001) 2.05
Fatal asthma attack during an inhalation challenge with ultrasonically nebulized distilled water. J Allergy Clin Immunol (1995) 2.04
Incidence of familial melanoma and MLM2 gene. Lancet (1994) 2.03
A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. Biomarkers (2007) 2.02
Propofol for adult procedural sedation in a UK emergency department: safety profile in 1008 cases. Br J Anaesth (2013) 2.01
Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med (1995) 1.96
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax (2001) 1.95
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med (1984) 1.95
General practitioners and child protection case conferences. BMJ (1991) 1.95
Location of cellular adhesions to solid substrata. Dev Biol (1973) 1.94
The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax (2008) 1.93
beta-adrenergic agonist resistance in normal human airways. Lancet (1977) 1.91
Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines. J Virol (1985) 1.91
Electrocardiographic changes subsequent to artificial ventricular depolarization. Br Heart J (1969) 1.88
Opening propofol ampoules. Anaesthesia (1998) 1.88
The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest (2001) 1.85
Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. A longitudinal study. Am Rev Respir Dis (1989) 1.82
Human enteric defensins. Gene structure and developmental expression. J Biol Chem (1996) 1.82
Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc Natl Acad Sci U S A (1980) 1.82
Natural history of asthma in childhood--a birth cohort study. Arch Dis Child (1991) 1.82
Two types of chloride channel on duct cells cultured from human fetal pancreas. Am J Physiol (1989) 1.81
Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med (1996) 1.81
Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol (1993) 1.78
What's new about hay fever? Br Med J (Clin Res Ed) (1985) 1.76
Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis (1992) 1.75
Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am J Respir Crit Care Med (2000) 1.75
Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol (1995) 1.74
Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell (1988) 1.73
Effect of atopy on the natural history of symptoms, peak expiratory flow, and bronchial responsiveness in 7- and 8-year-old children with cough and wheeze. A 12-month longitudinal study [published errarum appears in Am Rev Respir Dis 1992 Aug;146(2):540]. Am Rev Respir Dis (1991) 1.73
Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. Br Med J (Clin Res Ed) (1984) 1.73
Peak flow based asthma self-management: a randomised controlled study in general practice. British Thoracic Society Research Committee. Thorax (1995) 1.72
Different airway inflammatory responses in asthmatic and healthy humans exposed to diesel. Eur Respir J (2004) 1.71
Inhibition of adenosine 5'-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide. Eur Respir J (1990) 1.70
Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax (2004) 1.69
Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med (1986) 1.69
Violence in general practice. BMJ (1989) 1.68
Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66
Associations between respiratory symptoms, bronchial response to methacholine, and atopy in two age groups of schoolchildren. Arch Dis Child (1989) 1.66
Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax (1997) 1.65